Related Experiment Videos
[Chronobiology and chronopharmacology of cardiovascular diseases]
1Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim, Ruprecht-Karls-Universität, Heidelberg, Deutschland.
Insights
Circadian rhythms significantly influence heart conditions and how cardiovascular drugs work. Understanding this biological clock is crucial for effective medication timing and dosage in patients.
Area of Science:
- Chronobiology
- Cardiovascular Physiology
- Pharmacology
Context:
- Physiological functions and pathophysiological events, including angina pectoris, myocardial infarction, and sudden cardiac death, exhibit significant circadian rhythms.
- Clinical studies demonstrate a circadian phase dependency in the pharmacokinetics of cardiovascular drugs.
- These findings highlight the importance of the body's internal clock in cardiovascular health and drug efficacy.
Purpose:
- To review the evidence for circadian rhythms in cardiovascular physiology and pathophysiology.
- To examine the impact of circadian rhythms on the pharmacokinetics and pharmacodynamics of cardiovascular drugs.
- To emphasize the need to consider circadian variations in drug dosing and treatment strategies for cardiovascular diseases.
Summary:
- Cardiovascular events and functions show distinct daily rhythms.
- The body processes cardiovascular drugs differently depending on the time of day.
- This time-dependent drug behavior affects how well medications work and their potential side effects.
Impact:
- Informs the development of chronotherapy for cardiovascular diseases.
- Suggests personalized medicine approaches based on individual circadian patterns.
- Aims to optimize treatment outcomes and reduce adverse drug reactions in cardiovascular medicine.
Abstract:
Physiological functions as well as pathophysiological events--angina pectoris, myocardial infarction, sudden cardiac death--display pronounced circadian rhythms. Clinical studies also give evidence for a circadian phase dependency in the pharmacokinetics of cardio-vascular active drugs. Thus, a circadian phase dependency in the dose-response relationship of drugs has to be taken into account.